Literature DB >> 5782312

Sclerodermatous involvement of the stomach and the small and large bowel.

R D Peachey, B Creamer, J W Pierce.   

Abstract

Entities:  

Mesh：

Year:  1969        PMID： 5782312      PMCID： PMC1552842          DOI： 10.1136/gut.10.4.285

Source DB:  PubMed          Journal:  Gut        ISSN： 0017-5749            Impact factor:   23.059


× No keyword cloud information.
  17 in total

1.  Visceral scleroderma without skin involvement.

Authors:  S CROWN
Journal:  Br Med J       Date:  1961-12-09

2.  Scleroderma of the gastrointestinal tract; a review.

Authors:  M B GOLDGRABER; J B KIRSNER
Journal:  AMA Arch Pathol       Date:  1957-09

3.  Collagen disease of the small bowel.

Authors:  I MARSHALL
Journal:  N Engl J Med       Date:  1956-11-22       Impact factor: 91.245

4.  Scleroderma (diffuse systemic sclerosis).

Authors:  E R CULLINAN
Journal:  Proc R Soc Med       Date:  1953-07

5.  Steatorrhoea in Progressive Systemic Sclerosis (Scleroderma).

Authors:  D J McBrien; H E Mummery
Journal:  Br Med J       Date:  1962-12-22

6.  Progressive systemic sclerosis.

Authors:  R A Harper; D C Jackson
Journal:  Br J Radiol       Date:  1965-11       Impact factor: 3.039

7.  Malabsorption in intestinal scleroderma. Correction by antibiotics.

Authors:  I J Kahn; G H Jeffries; M H Sleisenger
Journal:  N Engl J Med       Date:  1966-06-16       Impact factor: 91.245

8.  Control of malabsorption in scleroderma.

Authors:  I S Cliff; R Herber; D J Demis
Journal:  J Invest Dermatol       Date:  1966-11       Impact factor: 8.551

9.  Small intestinal lesions with steatorrhea in diffuse systemic sclerosis (scleroderma).

Authors:  F D ROSENTHAL
Journal:  Gastroenterology       Date:  1957-02       Impact factor: 22.682

10.  Roentgen manifestations in progressive systemic sclerosis (diffuse scleroderma).

Authors:  B GONDOS
Journal:  Am J Roentgenol Radium Ther Nucl Med       Date:  1960-08
View more
  10 in total

1.  Intestinal Pseudo-obstruction.

Authors: 
Journal:  Br Med J       Date:  1973-01-13

2.  Pseudo-obstruction of the bowel. Therapeutic trial of metoclopramide.

Authors:  A B Lipton; C M Knauer
Journal:  Am J Dig Dis       Date:  1977-03

3.  Spontaneous perforation of the small intestine due to scleroderma.

Authors:  W M Battle; G K McLean; J J Brooks; H Herlinger; B W Trotman
Journal:  Dig Dis Sci       Date:  1979-01       Impact factor: 3.199

Review 4.  Intestinal malabsorption and the skin.

Authors:  J Marks; S Shuster
Journal:  Gut       Date:  1971-11       Impact factor: 23.059

Review 5.  Octreotide in gastrointestinal motility disorders.

Authors:  C Owyang
Journal:  Gut       Date:  1994       Impact factor: 23.059

6.  Effect of octreotide and erythromycin on idiopathic and scleroderma-associated intestinal pseudoobstruction.

Authors:  G N Verne; E Y Eaker; E Hardy; C A Sninsky
Journal:  Dig Dis Sci       Date:  1995-09       Impact factor: 3.199

7.  Anorectal dysfunction and delayed colonic transit in patients with progressive systemic sclerosis.

Authors:  G Basilisco; R Barbera; M Vanoli; P Bianchi
Journal:  Dig Dis Sci       Date:  1993-08       Impact factor: 3.199

8.  Intestinal involvement in progressive systemic sclerosis detected by increased unconjugated serum bile acids.

Authors:  F Stellaard; T Sauerbruch; C H Luderschmidt; B Leisner; G Paumgartner
Journal:  Gut       Date:  1987-04       Impact factor: 23.059

9.  Pyloric stenosis in a patient with progressive systemic sclerosis.

Authors:  M Hirakata; M Akizuki; Y Okano; N Hama; T Tojo; H Asakura; K Kumai; K Ishibiki; Y Hosoda; M Homma
Journal:  Clin Rheumatol       Date:  1988-09       Impact factor: 2.980

10.  Autoimmune enteropathy and colitis: is there a generalised autoimmune gut disorder?

Authors:  S M Hill; P J Milla; G F Bottazzo; R Mirakian
Journal:  Gut       Date:  1991-01       Impact factor: 23.059
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.